Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

NCT06443684 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT06443684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06443684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
Lead sponsor
Shanghai Chest Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
May 8, 2023
Completion date
December 31, 2027
Enrollment
305 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer